Want to see RAPP full AI Analyst Report?
Rapport Therapeutics, Inc. (RAPP) Technical Analysis
Technical Sentiment
Overall ConsensusSell
13Bearish
5Neutral
4Bullish
Technical Analysis ConsensusSell
3Bearish
5Neutral
2Bullish
Moving Average ConsensusStrong Sell
10Bearish
0Neutral
2Bullish
1 Day timeframe · Data as of Oct 30, 2026
- Rapport Therapeutics, Inc.’s (RAPP) Moving Averages Convergence Divergence (MACD) indicator is -3.21, suggesting Rapport Therapeutics, Inc. is a Sell.
- Rapport Therapeutics, Inc.’s (RAPP) 20-Day exponential moving average is $28.24, while Rapport Therapeutics, Inc.’s (RAPP) share price is $25.05, making it a Sell.
- Rapport Therapeutics, Inc.’s (RAPP) 50-Day exponential moving average is $33.55, while Rapport Therapeutics, Inc.’s (RAPP) share price is $25.05, making it a Sell.
Rapport Therapeutics, Inc. (RAPP) Pivot Points
1 Day timeframe · Data as of Oct 30, 2026
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 19.32 | 20.92 | 22.56 | 24.16 | 25.81 | 27.40 | 29.05 |
| Fibonacci | 20.92 | 22.16 | 22.92 | 24.16 | 25.40 | 26.16 | 27.40 |
Rapport Therapeutics, Inc. (RAPP) Moving Averages
1 Day timeframe · Data as of Oct 30, 2026
| Period | Simple | Exponential |
|---|---|---|
| MA5 | 24.93Buy | 24.99Buy |
| MA10 | 26.01Sell | 25.96Sell |
| MA20 | 27.97Sell | 28.24Sell |
| MA50 | 36.70Sell | 33.55Sell |
| MA100 | 39.25Sell | 36.12Sell |
| MA200 | 35.65Sell | 34.28Sell |
- Rapport Therapeutics, Inc.’s (RAPP) 10-Day exponential moving average is $25.96, while Rapport Therapeutics, Inc.’s (RAPP) share price is $25.05, making it a Sell.
- Rapport Therapeutics, Inc.’s (RAPP) 100-Day exponential moving average is $36.12, while Rapport Therapeutics, Inc.’s (RAPP) share price is $25.05, making it a Sell.
- Rapport Therapeutics, Inc.’s (RAPP) stock price is $25.05 and Rapport Therapeutics, Inc.’s (RAPP) 50-day simple moving average is $36.70, creating a Sell signal.
- Rapport Therapeutics, Inc.’s (RAPP) stock price is $25.05 and Rapport Therapeutics, Inc.’s (RAPP) 100-day simple moving average is $39.25, creating a Sell signal.
- Rapport Therapeutics, Inc.’s (RAPP) stock price is $25.05 and Rapport Therapeutics, Inc.’s (RAPP) 200-day simple moving average is $35.65, creating a Sell signal.
Rapport Therapeutics, Inc. (RAPP) Technical Indicators
1 Day timeframe · Data as of Oct 30, 2026
| Name | Value | Implied Action |
|---|---|---|
| RSI (14) | 37.55 | Neutral |
| STOCH (9,6) | 20.10 | Neutral |
| STOCHRSI (14) | 20.10 | Neutral |
| MACD (12,26) | -3.21 | Sell |
| ADX (14) | 43.82 | Neutral |
| Williams %R | -67.68 | Buy |
| CCI (14) | -108.73 | Buy |
| ATR (14) | 2.68 | - |
| Ultimate Oscillator | 35.85 | Neutral |
| ROC | -16.92 | Sell |
- Rapport Therapeutics, Inc.’s (RAPP) Relative Strength Index (RSI) is 37.55, creating a Neutral signal.
- Rapport Therapeutics, Inc.’s (RAPP) Trend Strength Indicator (ADX) is 43.82, creating a Neutral signal.
- Rapport Therapeutics, Inc.’s (RAPP) Commodity Channel Index (CCI) is -108.73, creating a Buy signal.
- Rapport Therapeutics, Inc.’s (RAPP) Price Rate of Change (ROC) is -16.92, creating a Sell signal.
unique trading strategy with a flexible screenerTry it Now!
FAQ
Is RAPP a Buy, Hold, or Sell?
Based on RAPP’s technical indicators on the 1-day timeframe as of Oct 30, 2026, RAPP is a Sell.
What is RAPP’s RSI (14)?
RAPP’s RSI (14) is 37.55, which suggests RAPP is a Neutral.
What is RAPP’s MACD?
RAPP’s MACD is -3.21, which suggests RAPP is a Sell.
What is RAPP’s 5-day moving average?
RAPP’s 5-day moving average is 24.93, which suggests RAPP is a Buy.
What is RAPP’s 20-day moving average?
RAPP 20-day moving average is 27.97, which suggests RAPP is a Sell.
What is RAPP’s 50-day moving average?
RAPP’s 50-day moving average is 36.70, which suggests RAPP is a Sell.
What is RAPP’s 200-day moving average?
RAPP’s 200-day moving average is 35.65, which suggests RAPP is a Sell.
What is RAPP’s Williams % R (14)?
RAPP’s Williams % R (14) is -67.68, which suggests RAPP is a Buy.
What is RAPP’s CCI (14)?
RAPP’s CCI (14) is -108.73, which suggests RAPP is a Buy.